Toripalimab Combined With CAV/IE Regimen

NCT04589741 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Soft Tissue Sarcoma

Interventions

DRUG: Toripalimab Combined With CAV/IE chemotherapy
DRUG: CAV/IE alternate chemotherapy

Sponsor

Sun Yat-sen University